Gladys Margot Cahuana

Gladys Margot Cahuana

Auto-generated profile, based on publicly available information

Gladys Margot Cahuana

Estefania Caballano-Infantes, José Terron-Bautista, Amparo Beltrán-Povea, Gladys M Cahuana, Francisco J Bedoya, Juan R Tejedo, Andalusian Center for Molecular Biology and Regenerative Medicine-University Pablo de Olavide, 41092 Seville, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in Experimental Cell Research
Verified
Journal Article
Closed access
GCGladys M Cahuana
Gladys M Cahuana
JTJuan R. Tejedo
Juan R. Tejedo
JJJuan Jiménez
Juan Jiménez
RRRemedios Ramı́rez
Remedios Ramı́rez
FSFrancisco Sobrino
Francisco Sobrino
Francisco Javier BedoyaFrancisco Javier Bedoya
Francisco Javier Bedoya

1 May 2004 in Endocrinology
Verified
Journal Article
Open access
PDF file
JTJuan R. Tejedo
Juan R. Tejedo
GCGladys M. Cahuana
Gladys M. Cahuana
RRRemedios RamírEz
Remedios RamírEz
MEMargarida Esbert
Margarida Esbert
JJJuan JiménEz
Juan JiménEz
Francisco Javier BedoyaFrancisco Javier Bedoya
Francisco Javier Bedoya
Mechanisms involved in the protective action of nitric oxide (NO) in insulin-producing cells are a matter of debate. We have previously shown that pharmacological inhibition of c-Src cancels the antiapoptotic action of low and sustained concentrations of exogenous NO. In this study, using insulin-producing RINm5F cells that overexpress Src either permanently active (v-Src) or dominant negative (dn-Src) forms, we determine that this tyrosine kinase is the principal mediator of the protective action of NO. We also show that Src-directed activation of insulin receptor substrate-1, phosphatidylinositol 3-kinase (PI3K), Akt, and Bad phosphorylation conform a substantial component of the survival route because pharmacological inhibition of PI3K and Akt canceled the antiapoptotic effects of NO. Studies performed with the protein kinase G (PKG) inhibitor KT-5823 revealed that NO-dependent activation of c-Src/ insulin receptor substrate-1 is not affected by PKG activation. By contrast, Akt and Bad activation are partially dependent on PKG activation. Endogenous production of NO after overexpression of endothelial nitric oxide synthase in RINm5F cells mimics the effects produced by generation of low amounts of NO from exogenous diethylenetriamine/NO. In addition, we found that NO produces c-Src/PI3K- and PKG-dependent activation of ERK 1/2. The MAPK kinase inhibitor PD 98059 suppresses NO-dependent protection from DNA fragmentation induced by serum deprivation. The protective action of low and sustained concentration of NO is also observed in staurosporine- and Taxol-induced apoptosis. Finally, NO also protects isolated rat islets from DNA fragmentation induced by serum deprivation. These data strengthen the notion that NO production at physiological levels plays a role in protection from apoptosis in pancreatic β-cells.

1 October 2001 in Experimental Cell Research
Verified
Journal Article
Closed access
JBJulio C. Bernabé
Julio C. Bernabé
JTJuan R. Tejedo
Juan R. Tejedo
PRPilar Rincón
Pilar Rincón
GCGladys M. Cahuana
Gladys M. Cahuana
RRRemedios Ramı́rez
Remedios Ramı́rez
Francisco Javier BedoyaFrancisco Javier Bedoya
Francisco Javier Bedoya

13 December 2016 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
EJEnrique Jurado‐Ruiz
Enrique Jurado‐Ruiz
LVLOURDES M VARELA
LOURDES M VARELA
ALAmparo Luque
Amparo Luque
GAGenoveva Berná Amorós
Genoveva Berná Amorós
GCGladys Cahuana
Gladys Cahuana
FMFranz Martín
Franz Martín

1 March 2012 in Islets
Verified
Journal Article
Closed access
PDF file
Francisco Javier BedoyaFrancisco Javier Bedoya
Francisco Javier Bedoya
CSCarmen Salguero-Aranda
Carmen Salguero-Aranda
GCGladys M. Cahuana
Gladys M. Cahuana
RTRafael Tapia-Limonchi
Rafael Tapia-Limonchi
BSBernat Soria
Bernat Soria
JTJuan R. Tejedo
Juan R. Tejedo
The reduction of pancreatic β-cell mass is an important factor in the development of type 1 and type 2 diabetes. Understanding the mechanisms that regulate the maintenance of pancreatic β-cell mass as well as β-cell death is necessary for the establishment of therapeutic strategies. In this context, nitric oxide (NO) is a diatomic, gaseous, highly reactive molecule with biological activity that participates in the regulation of pancreatic β-cell mass. Two types of cellular responses can be distinguished depending on the level of NO production. First, pancreatic β-cells exposed to inflammatory cytokines, lipid stress or hyperglycaemia produce high concentrations of NO, mainly due to the activation of inducible NO synthase (iNOS), thus promoting cell death. Meanwhile, under homeostatic conditions, low concentrations of NO, constitutively produced by endothelial NO synthase (eNOS), promote cell survival. Here, we will discuss the current knowledge of the NO-dependent mechanisms activated during cellular responses, emphasizing those related to the regulation of cell survival.

1 November 2001 in Cellular Signalling
Verified
Journal Article
Closed access
JTJuan R. Tejedo
Juan R. Tejedo
RRRemedios Ramı́rez
Remedios Ramı́rez
GCGladys M Cahuana
Gladys M Cahuana
PRPilar Rincón
Pilar Rincón
FSFrancisco Sobrino
Francisco Sobrino
Francisco Javier BedoyaFrancisco Javier Bedoya
Francisco Javier Bedoya